Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
Abstract Background Epistaxis is the most common symptom of hereditary hemorrhagic telangiectasia (HHT), affecting more than 98% of adults with HHT, with significant impact on quality of life. Floseal® has been shown to be effective for the management of anterior epistaxis, but has yet to be thoroug...
Saved in:
| Main Authors: | John M. Lee, Vincent Wu, Marie E. Faughnan, Andrea Lasso, Andrea Figol, Shaun J. Kilty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-10-01
|
| Series: | Journal of Otolaryngology - Head and Neck Surgery |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40463-019-0379-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of the COVID-19 pandemic on epistaxis and anaemia in patients with hereditary haemorrhagic telangiectasia (HHT) in central South Africa
by: Stephanie Juané Kennedy, et al.
Published: (2025-07-01) -
Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report
by: Meir Mei-Zahav, et al.
Published: (2017-10-01) -
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial
by: Scott Murray, et al.
Published: (2018-01-01) -
Overcoming Complexity: Percutaneous Embolization for Hepatic Artery Pseudoaneurysms in Hereditary Hemorrhagic Telangiectasia (HHT)
by: Anjali Sah, et al. -
Coexistence of Hereditary Hemorrhagic Telangiectasia and Moyamoya Disease: A Case Report Highlighting a Potential Genetic Synergy
by: Liu S, et al.
Published: (2025-07-01)